News and Opinions
Human mesenchymal stem cells show promise in treating chronic lung infections
Durham, NC – A study released today in STEM CELLS Translational Medicine offers hope for those suffering from a chronic, difficult to treat condition called non-tuberculous mycobacteria (NTM) lung infection. The study describes how researchers at Case Western...
Longeveron Selected to Present at the 2021 World Stem Cell Summit Dr. Joshua Hare, Longeveron’s Chief Science Officer, to present during this year’s Longevity Session
MIAMI, April 27, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, announces it has been selected to...
Breakthrough Paper Outlines Path to Heart Regeneration After Cardiac Injury
ALACHUA, Fla. (PRWEB)April 21, 2021 - Cardiovascular disease kills more than 650,000 Americans annually.(1) Those who survive myocardial infarction remain at risk of death because the human heart has a very limited ability to repair itself. No one has yet found a...
Advancing the Development of Safe and Effective Regenerative Medicine Products
By: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research Link to article The U.S. Food and Drug Administration plays a vital role in facilitating the development and availability of innovative medical products. Products such as...
Clinical trial assesses stem cells’ ability to prevent major cause of preemie deaths
Durham, NC - A phase 2 clinical trial whose results were released today in STEM CELLS Translational Medicine might point to a way to overcome bronchopulmonary dysplasia (BPD), a major cause of death in preterm infants. The study, conducted by researchers at Samsung...
Fat grafts enhanced with ADSCs show promise in treating facial scleroderma
Durham, NC – A study released today in STEM CELLS Translational Medicine suggests a new way to correct facial atrophy of localized scleroderma (LoS) in patients. It shows how applying grafts made up of the patient’s own fat enhanced with adipose‐derived stem cells...
Registration open for the VIRTUAL World Stem Cell Summit and Regenerative Medicine Essentials Course June 14-18, 2021
Wellington, FL — On June 14-18, 2021, the Regenerative Medicine Foundation (RMF) and Wake Forest Institute for Regenerative Medicine (WFIRM) will broadcast the combined event showcasing global experts, luminaries and visionaries from government, science, medicine,...
Clinical Trial for Novel Investigational Treatment of Type 1 Diabetes Open for Enrollment in Miami
Diabetes Research Institute Investigators Will Lead the First Site Activated for the Vertex Study MIAMI, FL – April 6, 2021 – Researchers with the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine and Vertex Pharmaceuticals...
Stem cell therapy research could help patients with non-healing diabetic foot ulcers
Durham, NC – According to the results of a phase 1 clinical trial just published in STEM CELLS Translational Medicine, a new stem cell therapy shows promise of making diabetes-related amputations a thing of the past. The trial involved injecting diabetes patients...
Cell-Based Therapies Show Promise for Seriously Ill Patients with COVID-19
Federal Funding for Large-Scale, Randomized, Controlled Trials is Needed to Confirm Results and Help Bring Safe and Effective Treatments to Patients in Need Washington, DC (March 24, 2021) – A new report released by Alliance for Cell Therapy Now, an independent,...
Antioxidant-primed stem cells show promise in repairing bone damaged by radiation
Durham, NC – The standard of treatment for bone tumors is often two-fold: surgery to remove the cancerous section followed by raadiation therapy to ensure all the cancerous cells have been killed off. This is an effective way to defeat bone tumors; however, it often...
Longeveron’s Lomecel-B™ Approved by FDA for Compassionate Use for the Treatment of Child with Hypoplastic Left Heart Syndrome (HLHS)
MIAMI, March 11, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, announced today that the U.S. Food...
Stem cells derived from fat show promise as a treatment for mass radiation exposure
Durham, NC – Nuclear power offers an efficient, reliable way to provide energy to large populations – as long as all goes well. Accidents involving nuclear reactors such as those that took place in 1986 at Chernobyl and at Fukushima Daiichi after the March 2011...
Good Worldwide Launches Leaps.org to Rebuild Public Trust in Science and Journalism
Non-profit Editorial Platform Fosters Renewed Enthusiasm for Scientific Progress March 15, 2021 – LeapsMag, the award-winning online magazine created to encourage public discussion about scientific innovation, re-emerges today as Leaps.org, a non- profit media...
Study provides evidence that bone marrow cell injections help heal the brain after stroke
Summary: Longitudinal imaging study provides evidence in patients that autologous bone marrow cells may lead to a reduction in white matter injury compared with stroke patients who did not receive bone marrow cells. Durham, NC – Results of a clinical trial released...
Phase I clinical trial shows promise of adipose-derived stem cells in treating lymphedema
Results of a phase I clinical trial released in STEM CELLS Translational Medicine shows there is a strong possibility that stem cells may alleviate lymphedema, a chronic debilitating condition affecting up to one in three women treated for breast cancer. Durham, NC –...
HCP Busted for Selling Fake Stem Cell Therapy
—Assistant physician and Missouri state legislator indicted for wire fraud, other crimes by Kristina Fiore, Director of Enterprise & Investigative Reporting, MedPage Today February 4, 2021 - A Missouri state lawmaker and medical professional was indicted by a...
New institute to leverage experts to advance regenerative medicine
JANUARY 19, 2021 —UTSA has launched a collaborative research institute that will benefit people suffering from a variety of vascular and other medical issues. The lnstitute of Regenerative Medicine will provide a unique resource and collection of research and...
Karīna Narbute’s Research in Extracellular Vesicles Earns Her Young Investigator Award
Durham, NC – Karīna Narbute, Ph.D. is the latest recipient of STEM CELLS Translational Medicine’s Young Investigator Award. The award fosters advancements in the field of stem cells and regenerative medicine by honoring a young researcher who is the principal author...
Retinal cell transplant clears experimental hurdle toward treating blindness
International Society for Stem Cell Research Retinal cells derived from adult human eye stem cells survived when transplanted into the eyes of monkeys, an important early step in the validation of this approach for treating blindness, according to a study by Liu, et...
Join Regenerative Medicine Foundation
Join today and get access to our newsletter and exclusive updates about events
and all things happening with regenerative medicine.
Join Our Mailing List
Copyright © 2024 Regenerative Medicine Foundation, All rights reserved.